WORK Medical Technology Group (NASDAQ:WOK) was upgraded by analysts at
Wa
WORK Medical Technology Group LTD’s Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation
WORK Medical Technology Group (NASDAQ:WOK) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq [Yahoo! Finance]